Expanding Rural Health Cancer Control Capacity
2 other identifiers
interventional
33
1 country
4
Brief Summary
Through this pilot study, investigators will test an innovative approach to implement survivorship care planning at three sites located in or adjacent to rural counties. The pilot data will inform a subsequent multi-site Hybrid Type 3 Implementation-Effectiveness study that will assess both implementation and clinical effectiveness outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable cancer
Started Feb 2021
Longer than P75 for not_applicable cancer
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 12, 2021
CompletedFirst Posted
Study publicly available on registry
February 21, 2021
CompletedStudy Start
First participant enrolled
February 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2029
November 15, 2024
November 1, 2024
6.9 years
February 12, 2021
November 12, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Rate of improvement in adherence to survivorship plan (Survivorship Care Planning Experience Satisfaction Survey (1-5 Excellent - Poor)
Approximately 12 months
Measure effectiveness of Telehealth on survivorship care
Approximately 12 months
Estimate the facilitators to a future larger-scale implementation of guideline-based survivorship care planning in rural settings
Approximately 1 year
Estimate the barriers to a future larger-scale implementation of guideline-based survivorship care planning in rural settings
Approximately 1 year
Study Arms (1)
Survivorship care
EXPERIMENTALParticipants in rural areas will receive a telehealth (providing health-related services through electronic communication technologies) survivorship care plan in combination with assistance from a patient navigator.
Interventions
Patient navigator assistance for navigating the healthcare system and locating and utilizing beneficial resources
Individualized survivorship care plan
Eligibility Criteria
You may qualify if:
- Cancer patient at least 18 years of age at time of cancer therapy
- English-speaking with the ability to provide informed consent
- Received treatment for Stage 0 - III cancer with curative intent
- Completed cancer therapy within the previous 12 months (i.e., 12 months prior to consenting) and in complete remission
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Debra Friedmanlead
- National Cancer Institute (NCI)collaborator
Study Sites (4)
Baptist Cancer Center- Golden Triangle Columbus
Columbus, Mississippi, 39705, United States
Baptist Cancer Center - North Mississippi
Oxford, Mississippi, 38655, United States
Baptist Cancer Center- Bartlett
Bartlett, Tennessee, 38133, United States
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Debra Friedman, MD
Vanderbilt-Ingram Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Sponsor Investigator
Study Record Dates
First Submitted
February 12, 2021
First Posted
February 21, 2021
Study Start
February 26, 2021
Primary Completion (Estimated)
February 1, 2028
Study Completion (Estimated)
February 1, 2029
Last Updated
November 15, 2024
Record last verified: 2024-11